Correction to This Article
A "Numbers Game" graphic in the Nov. 28 Health section incorrectly attributed research on awareness of the human papillomavirus. The research was conducted by the Center for Excellence in Cancer Communication Research at the Annenberg School for Communication at the University of Pennsylvania. Also, it was recently presented to the American Association for Cancer Research, but it was not conducted for that group.
A "Numbers Game" graphic in the Nov. 28 Health section incorrectly attributed research on awareness of the human papillomavirus. The research was conducted by the Center for Excellence in Cancer Communication Research at the Annenberg School for Communication at the University of Pennsylvania. Also, it was recently presented to the American Association for Cancer Research, but it was not conducted for that group.
The Numbers Game
The Numbers Game
|
TOOLBOX
   Resize
COMMENT
 Discussion Policy
 CLOSE
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
Who's Blogging  |
56 In a survey of 635 adults, percentage who had ever heard about the human papillomavirus (HPV)
42 Percentage who
had heard about a safe new
vaccine for HPV
20 Percentage who had ever talked to a health care
provider about the common virus, which is sexually transmitted and usually harmless but can cause cancer in women
Source: a nationally representative survey of 635 adults -- 49 percent of them women -- conducted for the American Association for Cancer Research. The survey was conducted after the FDA this summer approved the HPV vaccine, Gardasil, which is recommended for girls and women ages 9 to 26.
